Clinical Trials Logo

Clinical Trial Summary

Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00407121
Study type Interventional
Source Asociación para Evitar la Ceguera en México
Contact
Status Withdrawn
Phase Phase 3
Start date December 2006
Completion date December 2006

See also
  Status Clinical Trial Phase
Recruiting NCT03399175 - Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease N/A
Recruiting NCT05496530 - Custom Needle Preparation for Suprachoroidal Steroid Injection (One Year Results) N/A
Completed NCT05031143 - Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment Phase 2/Phase 3